ArticleThe Lancet. Rheumatology2023

Mortality and immune-related adverse events after immune checkpoint inhibitor initiation for cancer among patients with pre-existing rheumatoid arthritis: a retrospective, comparative, cohort study.

Kaitlin R McCarter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.